AI Article Synopsis

  • Research highlights that humans cannot synthesize the sialic acid Neu5Gc, which is found in animal-derived cardiac tissues and bioprosthetic heart valves (BHV), making it a potential target for immune response.
  • Studies showed Neu5Gc expression in porcine and bovine cardiac tissues and BHV, with higher levels of Neu5Gc in pericardium compared to valve tissues.
  • Human antibodies specifically recognize Neu5Gc in BHV, suggesting that this immune response may contribute to the deterioration of bioprosthetic heart valves over time.

Article Abstract

Background: The two common sialic acids (Sias) in mammals are N-acetylneuraminic acid (Neu5Ac) and its hydroxylated form N-glycolylneuraminic acid (Neu5Gc). Unlike most mammals, humans cannot synthesize Neu5Gc that is considered foreign and recognized by circulating antibodies. Thus, Neu5Gc is a potential xenogenic carbohydrate antigen in bioprosthetic heart valves (BHV) that tend to deteriorate in time within human patients.

Methods: We investigated Neu5Gc expression in non-engineered animal-derived cardiac tissues and in clinically used commercial BHV, and evaluated Neu5Gc immunogenicity on BHV through recognition by human anti-Neu5Gc IgG.

Results: Neu5Gc was detected by immunohistochemistry in porcine aortic valves and in porcine and bovine pericardium. Qualitative analysis of Sia linkages revealed Siaα2-3>Siaα2-6 on porcine/bovine pericardium while the opposite in porcine aortic/pulmonary valve cusps. Similarly, six commercial BHV containing either porcine aortic valve or porcine/bovine/equine pericardium revealed Siaα2-3>Siaα2-6 expression. Quantitative analysis of Sia by HPLC showed porcine/bovine pericardium express 4-fold higher Neu5Gc levels compared to the porcine aortic/pulmonary valves, with Neu5Ac at 6-fold over Neu5Gc. Likewise, Neu5Gc was expressed on commercial BHV (186.3±16.9 pmol Sia/μg protein), with Neu5Ac at 8-fold over Neu5Gc. Affinity-purified human anti-Neu5Gc IgG showing high specificity toward Neu5Gc-glycans (with no binding to Neu5Ac-glycans) on a glycan microarray, strongly bound to all tested commercial BHV, demonstrating Neu5Gc immune recognition in cardiac xenografts.

Conclusions: We conclusively demonstrated Neu5Gc expression in native cardiac tissues, as well as in six commercial BHV. These Neu5Gc xeno-antigens were recognized by human anti-Neu5Gc IgG, supporting their immunogenicity. Altogether, these findings suggest BHV-Neu5Gc/anti-Neu5Gc may play a role in valve deterioration warranting further investigation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036590PMC
http://dx.doi.org/10.1111/xen.12260DOI Listing

Publication Analysis

Top Keywords

commercial bhv
20
neu5gc
14
human anti-neu5gc
12
bioprosthetic heart
8
heart valves
8
neu5gc expression
8
cardiac tissues
8
porcine aortic
8
analysis sia
8
revealed siaα2-3>siaα2-6
8

Similar Publications

Over the last decade, the annual Immunorad Conference, held under the joint auspicies of Gustave Roussy (Villejuif, France) and the Weill Cornell Medical College (New-York, USA) has aimed at exploring the latest advancements in the fields of tumor immunology and radiotherapy-immunotherapy combinations for the treatment of cancer. Gathering medical oncologists, radiation oncologists, physicians and researchers with esteemed expertise in these fields, the Immunorad Conference bridges the gap between preclinical outcomes and clinical opportunities. Thus, it paves a promising way toward optimizing radiotherapy-immunotherapy combinations and, from a broader perspective, improving therapeutic strategies for patients with cancer.

View Article and Find Full Text PDF

Introduction: Bovine viral diarrhea virus (BVDV), a positive-sense single-stranded RNA virus, causes significant economic losses in the cattle industry. Current diagnostic methods for BVDV exhibit variable sensitivity and specificity, underscoring the need for more rapid and accurate detection approaches. Here, we developed a novel competitive ELISA (cELISA) to detect antibodies against the BVDV E2 protein.

View Article and Find Full Text PDF

Polymeric artificial heart valves derived from modified diol-based polycarbonate polyurethanes.

Acta Biomater

December 2024

National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, PR China. Electronic address:

Article Synopsis
  • A new type of polycarbonate silicone polyurethane (SiPCU) was developed for use in artificial heart valves, designed to have the right mechanical properties and biocompatibility.
  • The synthesis involved a modified macromolecular diol (PCDL-HMDI-PCDL) and a hard segment made from HMDI and chain extenders, leading to improved phase mixing and mechanical characteristics.
  • Compared to traditional bioprosthetic heart valve materials, the new SiPCUs show better biocompatibility, reduced calcification, and improved performance in simulated conditions, making them a promising alternative for heart valve applications.
View Article and Find Full Text PDF

A modified U-Net to detect real sperms in videos of human sperm cell.

Front Artif Intell

September 2024

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Background: This study delves into the crucial domain of sperm segmentation, a pivotal component of male infertility diagnosis. It explores the efficacy of diverse architectural configurations coupled with various encoders, leveraging frames from the VISEM dataset for evaluation.

Methods: The pursuit of automated sperm segmentation led to the examination of multiple deep learning architectures, each paired with distinct encoders.

View Article and Find Full Text PDF

Synthetic antimicrobial peptides Bac-5, BMAP-28, and Syn-1 can inhibit bovine respiratory disease pathogens .

Front Vet Sci

August 2024

Department of Pathobiology and Population Medicine, College of Veterinary Medicine, Mississippi State University, Mississippi State, MS, United States.

Mass treatment with antibiotics at arrival has been the mainstay for bovine respiratory disease (BRD) control but there is an increase in antimicrobial-resistant bacteria being shed from treated cattle. BRD is a disease complex that results from the interaction of viruses or bacteria and susceptible animals with inappropriate immunity. With bacteria being the only feasibly treatable agent and the emergence of antimicrobial resistance, decreased efficacy of commonly used antibiotics could threaten livestock health.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!